Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ebumab Holding ApS
APS
Active
CVR 39807556
Ole Maaløes Vej 3, 2200
København N
Activities of head offices
·
NACE 7010
Est. 2018 · 7 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Activities of head offices
/
Ebumab Holding ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
-16
-87
Staff expenses
-1
-0
-1
-300
-0
EBITDA
-46
-57
-22
-316
-87
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-46
-57
-22
-316
-87
Net financials
157
185
242
266
75.756
Profit before tax
111
129
220
-50
75.670
Tax
-53
29
48
-11
35
Net profit
163
100
171
-39
75.635
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
6.541
5.579
5.745
5.684
5.769
Equity
5.373
5.473
5.644
5.605
5.684
Long-term debt
1.133
0
0
0
0
Short-term debt
35
106
101
78
85
Total debt
1.168
106
101
78
85
Financial ratios
5-year trend
EBITDA margin
-8687100.0%
This company
15.8%
Market median
54981746% below market
2021
2025
Equity ratio
98.5%
This company
38.2%
Market median
158% above market
2021
2025
Return on equity
1330.6%
This company
18.4%
Market median
7132% above market
2021
2025
Net profit margin
7563494900.0%
This company
8.1%
Market median
93376480147% above market
2021
2025
Asset turnover
-0.02×
This company
1.12×
Market median
102% below market
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
98% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ebumab Holding ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
